Recent updates

  • 19 Jun 2018 European Medicines Agency (EMA) strengthens measures to avoid use of valproate medicines in pregnancy Topic: Suicide risk management
  • 06 Jun 2018 European Medicines Agency (EMA) strengthens measures to avoid use of valproate medicines in pregnancy Topic: Absence seizures
  • 06 Jun 2018 European Medicines Agency (EMA) strengthens measures to avoid use of valproate medicines in pregnancy Topic: Focal seizures
  • 31 May 2018 US CDC no longer recommends dolutegravir as part of PEP regimen in early pregnancy or women of childbearing age Topic: Post-exposure HIV prophylaxis
  • 30 May 2018 US and EU drug regulators warn of possible increased risk of neural tube defects in babies born to women taking dolutegravir Topic: HIV infection
  • 18 May 2018 European Medicines Agency (EMA) strengthens measures to avoid use of valproate medicines in pregnancy Topic: Generalized seizures in children
  • 18 May 2018 European Medicines Agency (EMA) strengthens measures to avoid use of valproate medicines in pregnancy Topic: Schizoaffective disorder
  • 18 May 2018 European Medicines Agency (EMA) strengthens measures to avoid use of valproate medicines in pregnancy Topic: Migraine headache in children
  • 18 May 2018 European Medicines Agency (EMA) strengthens measures to avoid use of valproate medicines in pregnancy Topic: Generalized seizures
  • 15 May 2018 European Medicines Agency (EMA) strengthens measures to avoid use of valproate medicines in pregnancy Topic: Bipolar disorder in adults
  • 19 Apr 2018 Cochrane review shows laryngeal mask airway should be considered before intubation in near-term neonates requiring resuscitation Topic: Premature newborn care
  • 05 Apr 2018 US guidance recommends vancomycin or fidaxomicin first line for adults with C difficile infection Topic: Clostridium difficile-associated disease
  • 29 Mar 2018 US CDC recommends third dose of MMR vaccine during mumps outbreaks Topic: Mumps
  • 09 Mar 2018 Updated Endocrine Society guidelines on hormonal treatment of gender dysphoria Topic: Gender dysphoria in adults
  • 05 Mar 2018 MS drug daclizumab withdrawn worldwide because of safety concerns Topic: Multiple sclerosis
  • 01 Mar 2018 US CDC recommends new shingles vaccine for adults aged 50 and above Topic: Herpes zoster infection
  • 28 Feb 2018 Endovascular repair for ruptured AAA has better 3-year survival Topic: Abdominal aortic aneurysm
  • 16 Feb 2018 Antifibrinolytic treatment in acute severe hemorrhage must be immediate for maximum survival benefit Topic: Placental abruption
  • 16 Feb 2018 Antifibrinolytic treatment in acute severe hemorrhage must be immediate for maximum survival benefit Topic: Placenta previa
  • 02 Feb 2018 2017 revisions to the McDonald diagnostic criteria for multiple sclerosis Topic: Multiple sclerosis
  • 02 Feb 2018 Fingolimod: UK MHRA introduces new contraindications for patients with cardiovascular disorders Topic: Multiple sclerosis
  • 31 Jan 2018 Corticosteroids (glucocorticoids) do not reduce mortality in patients with septic shock Topic: Sepsis in adults
  • 29 Jan 2018 US guidelines recommend lowering diagnostic threshold for hypertension to 130/80 Topic: Essential hypertension
  • 16 Jan 2018 US FDA warns against using cough and cold medicines containing opioids in children Topic: Common cold
  • 15 Dec 2017 Amantadine extended-release formulation is approved by the Food and Drug Administration (FDA) for the treatment of dyskinesias in patients with PD Topic: Parkinson disease
  • 15 Dec 2017 Benefits of procalcitonin guided antibiotic therapy in sepsis Topic: Sepsis in adults
  • 11 Oct 2017 Landmark cohort study on long-term antiplatelet treatment use in over-75s (post myocardial infarction/stroke/TIA) and risk of major GI bleeding Topic: Transient ischemic attack